Crucell, Royal DSM deal

Crucell and DSM said their 50/50 JV, Percivia PER.C6 Development Center is now an autonomous, biopharmaceutical company focused on PER.C6-based biobetter proteins and mAbs. Biobetters are biopharmaceu...